The analytical and spectral studies were conducted at the Chemical Service Center for the collective use of Siberian Branch of the Russian Academy of Science. The 1H and 13C-NMR spectra for solutions of the compounds in CDCl3 were recorded on a Bruker AV-400 spectrometer (Bruker Corporation, Hanau, Germany; operating frequencies 400.13 MHz for 1H and 100.61 for 13C). The residual signals of the solvent were used as references (δH 7.27, δC 77.1 for CDCl3). Merck silica gel (63–200 μ) was used for the column chromatography. Thin-layer chromatography was performed on TLC Silica gel 60F254 (Merck KGaA, Darmstadt, Germany). The target compounds reported in this manuscript had a purity of at least 95% (HPLC). All chemicals were used as described unless otherwise noted. Reagent-grade solvents were redistilled prior to use. Synthetic starting materials, reagents, and solvents were purchased from Sigma-Aldrich (St. Louis, MO, USA), Acros Organics (Geel, Belgium), and AlfaAesar (Heysham, UK).
(R)-(+)-Usnic acid (+)-9 was purchased from Zhejiang Yixin Pharmaceutical Co., Ltd. (Lanxi, China). Compounds 3,4 were obtained using a known procedure. The spectra of the substances coincided with that in the literature [31 (link),32 (link)].
Free full text: Click here